glp-1 drugs canada 3M Canadian adults taking drugs, reshaping eating and spending, survey suggests GLP-1 Agonists Market Report 2025-2033,

Its whether theyre being prescribed safely, supported appropriately, and offered by companies that put long-term patient health above short-term growth

Van Bloemendaal L, IJzerman RG, Ten Kulve JS, Barkhof F, Konrad RJ, Drent ML, et al

Examples of incretin mimetics include liraglutide, exenatide, semaglutide, and dulaglutide

Last year, per-employee costs jumped 5.2 percent, and prescriptions remain the fastest-growing plan expense, according to the 2023 National Survey of Employer-Sponsored Health Plans

Additionally, there was minor skin irritation observed at the insertion sites on day 0

Glutides are generally preferred over -enatides because -enatides have not been shown to lower the risk of cardiovascular complications such as heart attack and stroke